483 related articles for article (PubMed ID: 36362014)
21. Endocannabinoid signaling and energy metabolism: a target for dietary intervention.
Kim J; Li Y; Watkins BA
Nutrition; 2011 Jun; 27(6):624-32. PubMed ID: 21470818
[TBL] [Abstract][Full Text] [Related]
22. Update on the endocannabinoid system as an anticancer target.
Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
[TBL] [Abstract][Full Text] [Related]
23. Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils.
Komarnytsky S; Rathinasabapathy T; Wagner C; Metzger B; Carlisle C; Panda C; Le Brun-Blashka S; Troup JP; Varadharaj S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067450
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis.
Kaur I; Behl T; Bungau S; Zengin G; Kumar A; El-Esawi MA; Khullar G; Venkatachalam T; Arora S
Life Sci; 2020 Sep; 257():118109. PubMed ID: 32698072
[TBL] [Abstract][Full Text] [Related]
25. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
Zou S; Kumar U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533978
[TBL] [Abstract][Full Text] [Related]
27. Exploration of Multiverse Activities of Endocannabinoids in Biological Systems.
Behl T; Makkar R; Sehgal A; Singh S; Makeen HA; Albratty M; Alhazmi HA; Meraya AM; Bungau S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628545
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid-Based Therapies.
Piomelli D; Mabou Tagne A
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():483-507. PubMed ID: 34516291
[TBL] [Abstract][Full Text] [Related]
29. Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.
Grimaldi C; Capasso A
Mini Rev Med Chem; 2012 Oct; 12(11):1119-26. PubMed ID: 22625418
[TBL] [Abstract][Full Text] [Related]
30. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.
Paredes-Ruiz KJ; Chavira-Ramos K; Orozco-Morales M; Karasu C; Tinkov AA; Aschner M; Santamaría A; Colín-González AL
Neurotox Res; 2021 Dec; 39(6):2072-2097. PubMed ID: 34741755
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological tools in endocannabinoid neurobiology.
Mor M; Lodola A
Curr Top Behav Neurosci; 2009; 1():87-110. PubMed ID: 21104381
[TBL] [Abstract][Full Text] [Related]
33. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
Khan H; Ghori FK; Ghani U; Javed A; Zahid S
Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
[TBL] [Abstract][Full Text] [Related]
35. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
37. The role of the endocannabinoid system in female reproductive tissues.
Walker OS; Holloway AC; Raha S
J Ovarian Res; 2019 Jan; 12(1):3. PubMed ID: 30646937
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies.
Janero DR; Vadivel SK; Makriyannis A
Int Rev Psychiatry; 2009 Apr; 21(2):122-33. PubMed ID: 19367506
[TBL] [Abstract][Full Text] [Related]
39. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
